KOE:085660

Chabiotech Co.,Ltd. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:43 UTC

Last close

n/aKRW

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-8.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-17.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.1%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

What it pays out is the furthest below its sector's middle: 0.01 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

282

2016-12-31 to 2025-12-31100 at the start282

Sales: 100.00 on 2016-12-31 to 282.30 on 2025-12-31, up 182%.

Profit

-651

2016-12-31 to 2025-12-31100 at the start-651

Profit: 100.00 on 2016-12-31 to -650.93 on 2025-12-31, down 751%.

Shares in issue

131

2016-12-31 to 2025-12-31100 at the start131

Shares in issue: 100.00 on 2016-12-31 to 130.86 on 2025-12-31, up 31%.

Sales is at 282, Profit is at -651, Shares in issue is at 131, against 100 in 2016.

Sales is at 282, Profit is at -651, Shares in issue is at 131, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100282
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit, where the first year is 100-651
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Shares in issue, where the first year is 100131
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW